Could a heart drug curb alcohol cravings? small study aims to find out
NCT ID NCT06900998
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study will test whether nimodipine, a drug usually used for blood pressure, can reduce alcohol drinking and cravings in heavy drinkers. Five adults with Alcohol Use Disorder will stay overnight at a hospital, take nimodipine, and then have the option to drink alcohol or receive money instead. Researchers will track how many drinks they choose and monitor any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale University School of Medicine (Connecticut Mental Health Center)
New Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a brain zapping headset curb relapse in addiction?
- Can a smartphone app tame Alcohol-Related liver disease?
- Calm in a room: can sensory therapy soothe the mind?
- Can a brief alcohol intervention improve mental health treatment?
- Smartphone support for sobriety: a trial tests digital tools in black communities
- Emergency room could be the starting point for alcohol addiction treatment